Akzo Nobel N.V.
AKZOF
$57.42
-$1.32-2.25%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -0.42% | -1.09% | 1.52% | -0.54% | -4.05% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.42% | -1.09% | 1.52% | -0.54% | -4.05% |
| Cost of Revenue | -1.89% | -1.56% | 1.98% | 1.91% | -2.31% |
| Gross Profit | 1.77% | -0.37% | 0.84% | -4.07% | -6.54% |
| SG&A Expenses | 2.48% | -3.07% | 1.50% | -0.29% | 0.37% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -427.17% | -30,567.42% | 5,706.33% | -110.90% | -3.07% |
| Total Operating Expenses | -0.53% | -13.90% | 13.69% | 1.11% | -1.39% |
| Operating Income | 0.87% | 238.29% | -108.40% | -15.49% | -27.66% |
| Income Before Tax | -4.50% | 757.55% | -141.33% | -22.65% | -34.99% |
| Income Tax Expenses | 6.78% | 159.13% | 29.82% | -12.46% | -18.37% |
| Earnings from Continuing Operations | -8.97% | 1,738.29% | -218.85% | -25.47% | -39.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 37.69% | 41.76% | 54.42% | 22.67% | -4.39% |
| Net Income | -5.22% | 3,009.76% | -226.57% | -26.13% | -42.69% |
| EBIT | 0.87% | 238.29% | -108.40% | -15.49% | -27.66% |
| EBITDA | 3.12% | 145.35% | -78.56% | -10.27% | -20.17% |
| EPS Basic | -5.45% | 3,003.43% | -226.42% | -26.26% | -42.76% |
| Normalized Basic EPS | 0.34% | 387.98% | -131.58% | -22.78% | -38.61% |
| EPS Diluted | -5.03% | 3,027.76% | -227.14% | -26.71% | -43.30% |
| Normalized Diluted EPS | 0.79% | 397.80% | -131.72% | -22.74% | -39.19% |
| Average Basic Shares Outstanding | 0.23% | 0.18% | 0.12% | 0.18% | 0.12% |
| Average Diluted Shares Outstanding | -0.21% | -1.81% | -0.34% | 0.12% | 1.07% |
| Dividend Per Share | -- | 9.20% | -- | 5.45% | -- |
| Payout Ratio | -0.42% | -0.98% | -5.54% | 0.41% | 0.27% |